| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 11 | -600K | 100% | $62.68 | -$37.6M |
| Net | -11 | -600K | -100% | -$37.6M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Meridian Venture Partners II Lp | 10%+ Owner | $103M | Aug 16, 2023 | ||
| Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS, Director | $43.8M | -$20.7M | -32.1% | Jul 18, 2024 |
| Nikhil Lalwani | PRESIDENT & CEO, Director | $25.6M | -$6.03M | -19.1% | Nov 26, 2024 |
| Chad Gassert | Svp Corp. Dev. & Strategy | $15.4M | -$6.55M | -29.8% | Jul 1, 2024 |
| Stephen P. Carey | Svp & Cfo | $10.3M | -$828K | -7.44% | Jun 4, 2024 |
| James G. Marken | Svp Ops & Prod Dev | $7.98M | -$1.62M | -16.8% | Jun 7, 2024 |
| Ori Gutwerg | Svp, Generics | $5.62M | -$200K | -3.44% | Jun 5, 2024 |
| Patrick D. Walsh | Director | $4.6M | May 21, 2024 | ||
| Christopher Mutz | Head Of Rare Disease | $4.43M | -$828K | -15.8% | Nov 15, 2024 |
| Thomas Haughey | Director | $3.17M | May 21, 2024 | ||
| Meredith Cook | Sr. Vp, General Counsel & Sec. | $3.15M | -$184K | -5.51% | Dec 13, 2024 |
| Krista Davis | Svp, Chief Hr Officer | $2.94M | -$60K | -2% | Dec 11, 2024 |
| Robert E. Brown JR | Director | $2.77M | Apr 27, 2022 | ||
| Jeanne Thoma | Director | $2.5M | May 21, 2024 | ||
| David Nash | Director | $2.18M | May 23, 2023 | ||
| Antonio R. Pera | Director | $1.91M | -$456K | -19.3% | May 21, 2024 |
| Thomas Rowland | Svp, Head Established Brands | $1.88M | Nov 15, 2024 | ||
| Renee P. Tannenbaum | Director | $1.39M | -$128K | -8.4% | May 21, 2024 |
| Matthew J. Leonard | Director | $739K | May 21, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|